It contains tirzepatide, a dual GIP and GLP-1 receptor agonist that works on key pathways involved in appetite regulation, blood sugar control, and metabolic function
Strategy or dysfunction Obesity is recognized by major medical organizations as a chronic disease associated with increased risk of diabetes, cardiovascular disease, and sleep apnea
Always consult a healthcare provider if you are unsure about the appearance of your medication
145 Under oxidative stress, Cys34 thiol shifts to a sulfenic acid (HSA-SOH), which can be irreversibly oxidized to the sulfinic (HSA-SO2H) and sulfonic (HSA-SO3H) acids or, through the reactions with glutathione, can be returned to the HSA-SH reduced form
Horn, DO, MPH, DABOM, MFOMA, medical director at the University of Texas Center for Obesity Medicine and Metabolic Performance and clinical assistant professor in the department of surgery at University of Texas McGovern Medical School in Houston, said the weight loss observed in ATTAIN-2 was lower than what was observed in ATTAIN-1, but added that adults with type 2 diabetes usually lose less weight with obesity pharmacotherapy than the nondiabetes population
Limiting your alcohol intake and not taking prohibited drugs are other risk factors you can manage
